| 10/05 | GENEART and GENOVAC team up on research antibodies
(download as PDF) |
| | |
| 05/05 | GENOVAC startet Projekt zur Produktion von funktionellen anti-GPCR-Antikörpern (IMPACT) - Baden-Württemberg fördert das innovative Forschungsvorhaben der GENOVAC GmbH (Text only in German; download as PDF). |
| | |
| 02/04 | GENOVAC has been purchased by the US company Aldevron LLC with effect on 1st January 2004. |
| | |
| 01/04 | GENOVAC generated a monoclonal antibody blocking a native GPCR. Published by Elagoz et al. in Br J Pharmacol. 2004 Jan, 141(1): 37-46. |
| | |
| 07/03 | GENOVAC grants NOSAN license to the application of its proprietary antibody production technology in Japan.(press release 280703) |
| | |
| 06/03 | GATC and GENOVAC co-operate in the Field of Antibody Production. Both Companies envisage a long-term partnership.(press release 020603) |
| | |
| 01/03 | GENOVACs Technology Tested and Approved by CuraGen. (press release 300103) |
| | |
| 11/02 | Products for Drug Development in Japan. (press release 121102) |
| | |
| 06/02 | Baden-Württemberg's Wirtschaftsminister Walter Döring besucht auf BIO 2002 in Toronto die GENOVAC AG. (Text only in German, press release 260602) |
| | |
| 01/02 | In preparation for high-throughput antibody production GENOVAC has purchased a highly integrated automation system which will guarantee reproducibility and high quality for the GENOVAC priority screening method. |
| | |
| 12/01 | GENOVAC is proud to announce that Rüdiger Hurrle has joined our supervisory board. Mr Hurrle is founder of the MediClin AG and has recently been named as a consultant in the development of a new Biomedical Centre (BMZ) at the Ludwigs-Maximilian-University of Munich in Martinsried-Grosshadern. |
| | |
| 12/01 | Cooperation accelerates the development of therapeutic antibodies. (press release 131201) |
| | |
| 12/01 | With the current round of financing GENOVAC will begin implementing their business plan, in particluar the development of their own products. This second round will be financed by three investors. |
| | |
| 10/01 | The direct way from gene to antibody: A new perspective for medicine in the 21st century. (press release 241001) |
| | |
| 06/01 | GENOVAC is proud to announce that Ralph Reisfeld has joined our scientific advisory board. Dr Reisfeld is Professor at the Department of Immunology at the Scripps Research Institute in La Jolla, California. |
| | |
| 01/01 | For their technology, GENOVAC was recently awarded the 1st prize in the "Freiburger Innovationspreis 2000" out of a total of over 30 companies. |
| | |
| |
| | |
| |
| | |
| |
| | |
| |
| | |
